Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02991898
Recruitment Status : Suspended (Considering new technology for product.)
First Posted : December 14, 2016
Last Update Posted : September 6, 2018
Sponsor:
Information provided by (Responsible Party):
Masonic Cancer Center, University of Minnesota

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : January 2025
  Estimated Study Completion Date : January 2025